Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Science Group Plc LSE:SAG London Ordinary Share GB00B39GTJ17 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 345.00 340.00 350.00 345.00 345.00 345.00 0.00 07:43:59
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 73.7 6.4 16.9 20.4 142

Science Group PLC Trading, Business and Board Update

11/01/2021 7:00am

UK Regulatory (RNS & others)


Science (LSE:SAG)
Historical Stock Chart


From Nov 2020 to May 2021

Click Here for more Science Charts.

TIDMSAG

RNS Number : 1228L

Science Group PLC

11 January 2021

 
 
     11 J anuary 2021 
 

Science Group plc

(the "Company", "Group" or "Science Group")

Trading, Business and Board Update

Science Group provides a trading update for the 12 months to 31 December 2020.

Group revenue for the year is now anticipated to be in the order of GBP73 m illion (2019: GBP57.2 million). While the Board took the opportunity during the second half of the year to increase investment in infrastructure and personnel, early indications are that, subject to audit, the Group's adjusted operating profit for the year ended 31 December 2020 will exceed the previously upgraded expectations of GBP10 million (2019: GBP6.7 million).

In the first half of the year, the Group received funding for furloughed employees under the UK Government scheme. While less than GBP0.1 million, this was an appropriately prudent action taken as part of a wider programme at a time of uncertainty. The Board elected to repay such monies received from the UK Government in the second half of 2020.

At 31 December 2020, the Group had cash (excluding client funds) of GBP27.1 million (2019: GBP13.9 million) and net funds of GBP10.6 million (2019: net debt of GBP2.3 million). While the dividend payment was reduced in 2020, in aggregate GBP2.4 million was returned to shareholders through a combination of share buy-backs and dividends compared with an aggregate of GBP2.0 million in 2019.

The Group's cash now exceeds the level prior to the Frontier acquisition, enabling the Board to explore further strategic opportunities, should they arise. Over the past decade, Science Group's self-funded model has enabled the Group to grow revenue more than 3-fold and adjusted operating profit 4-fold, without shareholder dilution.

Due to the increasing severity of the pandemic and the associated restrictions, the Board anticipates that the audit process for the year ended 31 December 2020 will take longer than usual. The preliminary results for the year are consequently anticipated to be released in mid to late March. The Board does not anticipate providing any further update regarding 2020 performance until the preliminary results are released.

Board Change

After almost 7 years with the Group, Rebecca Archer, Group Finance Director, has advised the Board of her intention to resign to take up a new role. Rebecca has made a significant contribution to Science Group and leaves with the Board's best wishes for the future.

The Board is pleased to announce that Sameet ("Sam") Vohra has accepted the position of Chief Financial Officer Designate. Sam qualified as a Chartered Accountant with KPMG and has gained considerable experience in senior finance leadership roles in UK listed international businesses, including Group Financial Controller at TT Electronics PLC and Group Director of Finance at Spectris PLC, the FTSE 250 precision engineering company. Most recently, he was Interim Group Finance Director at Ted Baker PLC during their financial restructuring.

Rebecca will leave the Group after completion of the 2020 audit and the posting of the Annual Report to shareholders. It is anticipated that Sam will be appointed to the Board in January with the formal transfer being completed in April. Over the next few months, a handover of responsibilities will be effected.

Frontier Smart Technologies ("Frontier")

Since the acquisition in 2019, the restructuring and turnaround of Frontier has been very successful, resulting in an excellent performance in 2020. Frontier is now a strongly profitable technology business with a market leading position. Confirmed orders at the start of 2021 are very healthy and shipments in the first part of the year may be supply constrained.

Frontier has a different product-based business model to the services provided by the Group's other Divisions. As previously indicated, the long-term strategy for Frontier has always been a subject for further review once the turnaround was satisfactorily completed. At the current time, the Board considers the key options to be: (i) to retain the business within the Group and maximise the profit and cash flow contribution; (ii) to increase operating scale through the merger or acquisition of a similar business or businesses; or (iii) to sell all or part of the business. The Board and the Frontier management team continue to consider all these alternatives and have now decided to initiate a more formal process, including appointing external advisers, to determine the best approach. This process may take some time and the Board remains open minded as to the outcome. Further announcements will be made at the relevant time.

 
 Science Group plc 
                                             Tel: +44 (0) 1223 875 
 Martyn Ratcliffe, Chairman                                    200 
                                              www.sciencegroup.com 
 
 Stifel Nicolaus Europe Limited (Nominated 
  Adviser and Joint Broker) 
                                              Tel: +44 (0) 20 7710 
 Nick Adams, Alex Price                                       7600 
 
 Liberum Capital Limited (Joint Broker) 
                                              Tel: +44 (0) 20 3100 
 Neil Patel, Cameron Duncan                                   2000 
 
 
 
 
 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014). The person responsible for this announcement is Martyn Ratcliffe .

Regulatory disclosures

Pursuant to Schedule 2(g) of the AIM Rules for Companies, Sameet Vohra (aged 47) has held the following directorships or partnerships in the past five years:

Current directorships and partnerships :

The Grange Wraylands Drive Reigate Ltd

Directorships/partnerships held in the past five years:

None

Sameet Vohra does not currently hold any shares in the Company.

There is no further information to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTUWOSRANUARAR

(END) Dow Jones Newswires

January 11, 2021 02:00 ET (07:00 GMT)

1 Year Science Chart

1 Year Science Chart

1 Month Science Chart

1 Month Science Chart
ADVFN Advertorial
Your Recent History
LSE
SAG
Science
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210514 15:35:00